[{"symbol": "PSY", "assetClass": "Equity", "aum": 4676894, "avgVolume": 0, "cusip": "", "description": "The index is a rules-based index that tracks the performance of a portfolio of companies conducting legal activities under the national laws of the applicable country related to medical psychedelics, medical cannabis, cannabis pharmaceuticals and cannabidiol derivatives, and ketamine. The fund uses a \u201creplication\u201d strategy to achieve its investment objective, it will invest in all of the component securities of the index in the same approximate proportions as in the index. It is non-diversified.", "domicile": "US", "etfCompany": null, "expenseRatio": 0.75, "inceptionDate": "2021-05-27", "isin": "", "name": "Defiance Next Gen Altered Experience ETF", "nav": 5.93, "navCurrency": "USD", "sectorsList": [{"industry": "Basic Materials", "exposure": 0}, {"industry": "Communication Services", "exposure": 0}, {"industry": "Consumer Cyclical", "exposure": 6.43}, {"industry": "Consumer Defensive", "exposure": 5.65}, {"industry": "Energy", "exposure": 0}, {"industry": "Financial Services", "exposure": 0}, {"industry": "Healthcare", "exposure": 82.68}, {"industry": "Industrials", "exposure": 0}, {"industry": "Real Estate", "exposure": 5.25}, {"industry": "Technology", "exposure": 0}, {"industry": "Utilities", "exposure": 0}], "website": "", "holdingsCount": 2}]